Anne-Marie Duliege

Dr. Anne-Marie Duliege leads the Malaria team’s efforts to advance the development of antimalarial interventions, including drugs, diagnostics, vaccines, and monoclonal antibodies. She joined the foundation in 2023.

Anne-Marie has more than 30 years of experience in the biopharmaceutical and nonprofit sectors, including as a senior executive. Most recently, she served as Chief Medical Officer at PanCAN, an advocacy organization serving patients with pancreatic cancer. She has extensive experience in infectious diseases and immunology and has long been associated with many aspects of the fight against HIV/AIDS.

Anne-Marie serves on the board of the California Institute for Regenerative Medicine (stem cell research), Fe Pharmaceuticals (developing an innovative therapy for antibiotic-resistant infections), and Global Strategies (access to health care in developing countries).

She received her M.D. degree and certification in pediatrics from Paris Medical School, an M.S. in epidemiology from the Harvard School of Public Health, and an M.S. in biostatistics from Paris Medical School. She continues to practice pediatrics as an adjunct clinical assistant professor at Lucile Packard Children’s Hospital at Stanford.